clinical trials for semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo- controlled, phase 3 trial Semaglutide Safely Improves Metabolic Health

Choosing Between Tirzepatide and Semaglutide Tirzepatide vs

The impact of BMI on treatment response is well illustrated by the AQUILA study, which examined real-world outcomes in PsA patients treated with (65).In this cohort, obese individuals exhibited higher circulating levels of IL-17, supporting the concept that IL-17driven inflammation may be particularly prominent in this subgroup and may contribute to increased disease activity and reduced therapeutic responsiveness (66)

Pre-filled pens like Ozempic and Mounjaro typically use 31 or 32-gauge needles

We give detailed instructions and show patients how to do it themselves

These observations support continued investigation into how amylin receptor agonists affect metabolic regulation at a mechanistic level